Sure-Tech: When the Control Dispute Reaches Capital Allocation Itself
At Sure-Tech, the control fight is no longer background governance noise. Once the rights offering is stopped by court order, the supervisor seeks to limit follow-on authority, and the partnership itself funds the legal process in amounts described as immaterial, the dispute moves directly to who gets to decide on cash and where it goes.
The main article argued that Sure-Tech's gap is not only between reported portfolio value and market value. It is also between value on paper and the practical ability to reach it. This follow-up isolates the point where that gap stopped being a general idea and became a concrete dispute over the investment mechanism itself.
This is no longer only a fight over control. It is a fight over the two levers that keep a small listed investment partnership functioning: the ability to raise fresh capital, and the ability to make follow-on investments without turning every round into a legal clash as well.
| Date | What happened | Why it matters |
|---|---|---|
| December 4, 2024 | The partnership published a shelf-offering report for a rights offering | This was a practical capital-raising route for the partnership itself |
| December 10, 2024 | A temporary court order stopped the completion of the rights offering | The funding path was interrupted before it could be completed |
| November 25, 2025 | The limited partner and the supervisor asked the court to transfer NIS 200 thousand from the partnership's cash for legal advice | The dispute had already reached direct use of partnership cash |
| December 25, 2025 | The court rejected a request to bar investments in companies not expressly listed in section 5.1 and to transfer NIS 110 thousand plus VAT for independent representation | The conflict had already reached the authority to carry out follow-on investments |
| January 1, 2026 | Sure-Tech made an additional USD 750 thousand investment in Antidote, and on the same day another legal-funding request was filed | The investment track and the legal fight collided on the same day |
| January 25, 2026 | The parties agreed that the partnership would fund the supervisor's legal expenses in amounts not material to it | The accounting question became smaller, the governance question did not |
| February 15-16, 2026 | Doron Gedalyahu left the board, while Yitzhak Yahane entered and was classified as independent | Oversight composition changed, but financial management did not turn over |
The Blocked Rights Offering Turned Governance Into A Funding Question
The event that pushes this story from legal framing into economic reality is the blocked rights offering. In December 2024, several unit holders who claimed to hold about 6.69% of the participation units filed a lawsuit against the partnership and the general partner. They did not stop at oppression claims or dissolution. As alternative relief they also asked to replace the general partner through a competitive process and to distribute a NIS 30 million dividend in cash and cash equivalents.
Within that same process they also asked for an injunction to prevent completion of the rights offering published on December 4, 2024. On December 10, 2024, a temporary order was granted and the offering was not completed. After that, in a preliminary hearing held on December 3, 2025, the court suggested mediation, and as of the report date that is the path the parties are following.
The implication is sharp. Once the direct route for raising capital at the partnership level is blocked, every dispute about a follow-on investment stops being theoretical. It immediately becomes a question of where the cash will come from, who is allowed to deploy it, and what happens if even the legal fight over that authority is funded from the same limited pool.
That is why the remedies sought in December 2024 matter more than their tone. This was not just a fight over who should sit in control. It was an attempt to move three levers at once: control, cash distribution, and capital raising. That is already a capital-allocation fight, not just governance noise.
The Dispute With The Supervisor Reaches The Core Of The Investment Model
In July 2025, attorney Yehonatan Yanai was appointed as the partnership's supervisor after unit holders pushed to add his nomination to the meeting agenda, and the appointment was approved on July 10, 2025. From that point onward, the dispute no longer sat only between scattered holders and the general partner. It also sat inside the partnership's formal supervision mechanism.
On December 25, 2025, the court rejected an application submitted by the supervisor and the limited partner. That application was not only about funding representation. It also asked for a temporary injunction that would bar the general partner's board from discussing, deciding, or acting on investments in companies not expressly listed in section 5.1 of the partnership agreement, even if the partnership had already invested in them before.
That is the heart of the issue. If the supervisor's position were accepted, Sure-Tech would not merely be arguing about procedure or about who holds office. It would be arguing about whether it is allowed to continue supporting part of its existing portfolio without an explicit approval from the holders' meeting.
Under the supervisor's position, from May 2, 2024 onward the partnership is no longer allowed to make follow-on investments in portfolio companies that were invested in during the first three years after listing and are not specified in the partnership agreement, unless unit holders explicitly approve it. The partnership and the general partner rejected that position after two legal opinions were presented to them, including one from an independent corporate-law expert, together with an additional position paper from a professional who had worked for years on public limited partnerships at the Israel Securities Authority.
The general partner's response is not mild. It says the supervisor's interpretation does not match the parties' intent, does not fit accepted interpretive rules, conflicts with the limited partner non-involvement principle, runs against commercial logic, and materially harms the partnership's ability to invest and preserve the value of existing holdings.
So this is not a dispute at the margin. It goes straight to the ability of Sure-Tech to behave like a listed venture investment partnership, protect companies already in the portfolio, and keep managing them after the initial check has been written.
That chart is not the center of the dispute, but it explains why it can no longer be dismissed as a footnote. Within a few weeks, the discussion moved from a request for NIS 110 thousand plus VAT for independent representation, to a request for NIS 200 thousand for the limited partner's fund and at least NIS 65 thousand more plus VAT for the supervisor's legal costs. These are small amounts relative to the portfolio, but they show that the conflict is already generating real cash uses.
The Funding Compromise Did Not Resolve The Authority Question
The most revealing detail in the sequence is the timing. On January 1, 2026, the partnership disclosed an additional USD 750 thousand investment in Antidote under a new SAFE agreement. On that exact same day, the limited partner and the supervisor filed another application asking the court to transfer NIS 200 thousand to the limited partner's fund and to charge the general partner with the supervisor's legal costs in an amount not lower than NIS 65 thousand plus VAT.
That is not a technical coincidence. It highlights that the dispute now sits exactly at the meeting point between fresh money leaving the partnership for a portfolio company and money being requested to litigate whether such a move is allowed in the first place.
On January 25, 2026, the parties reached an agreement, following the court's suggestion, under which the partnership would fund the supervisor's legal expenses in amounts not material to it. The immediate report published on January 26, 2026 uses the same wording. That language rightly lowers the accounting noise. The amount is not described as material.
But analytically, the issue is not the size of the amount. It is the fact that the partnership is funding the dispute over the boundaries of its own investment authority. This was a procedural solution to representation. It did not resolve the basic question: are follow-on investments in part of the existing portfolio part of the general partner's ordinary authority, or do they require holder approval each time.
The best evidence that the core issue was not closed is what happened next. The supervisor told the general partner and the partnership that he did not accept their position and was considering legal proceedings on the matter. As of the report date, no such proceeding had yet been filed, but on March 9, 2026, after the balance-sheet date, he sent a letter stating that he intended to file the claim immediately.
The conclusion is straightforward: the January compromise solved the representation problem, not the authority problem. Anyone looking for operating calm did not get it.
The Board Seat Changed, But The Person Holding The Finance Function Did Not
February 2026 added another governance layer, but this also needs a precise reading. On February 15, 2026, Doron Gedalyahu stopped serving as a director by resignation. The immediate report states explicitly that the departure was not connected with circumstances requiring disclosure to holders. That matters, because the company is not signalling a personal rupture or an acute internal breakdown.
At the same time, the same filing makes clear that Gedalyahu continues to serve as CFO and EVP of business development. The company had also regarded him as a director with accounting and financial expertise. In other words, the board seat changed hands, but the finance function did not leave the system.
In parallel, on February 15, 2026, Yitzhak Yahane began serving as a director, and on February 16 the general partner's board classified him as independent and appointed him to the board committees. That adds an independence layer and a stronger oversight signal. It is not, by itself, a reset of the investment engine.
So the right reading is two-sided. The composition changed, but financial management stayed where it was. For the capital-allocation fight, that means Sure-Tech made a governance adjustment, not a full restart of the decision-making center. Anyone hoping to see a solution through management turnover did not get one. Anyone looking for a sign that the board is reacting to pressure did.
Bottom Line
Sure-Tech is no longer in a place where control conflict can be separated from portfolio management. The blocked rights offering, the dispute over follow-on authority, the requests to fund legal proceedings, and the February board change all lead back to the same question: who is allowed to move the money, and on what terms.
The follow-up thesis here is simple. The governance fight has reached capital allocation itself. Not because the company wrote more about it, but because the dispute now touches the partnership's own funding route, the authority to support portfolio companies, the financing of the legal fight around that authority, and the board composition overseeing all of it.
The counter-thesis is also serious. The court rejected the request to block follow-on investments, the general partner backs its view with substantial legal opinions, and the compromise on legal-funding was expressly described as not material to the partnership. One can argue that this is intense governance noise, but not yet paralysis.
Still, that does not solve the practical problem. As long as the rights offering remains stuck, and as long as the supervisor signals that another legal step is imminent, every portfolio investment decision carries a layer of interpretive risk alongside the business judgment itself. In a small listed investment partnership, that is not noise. It is friction applied directly to the model.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.